In accordance with current clinical practice, discontinuation of Zonegran in patients with epilepsy must be accomplished by gradual dose reduction, to reduce the possibility of seizures on withdrawal.
I overensstemmelse med gængs klinisk praksis skal seponering af Zonegran hos patienter med epilepsi ske ved gradvis dosisreduktion for at reducere risikoen for kramper i forbindelse med seponering.